Smith & Nephew, a global medical technology business, has named Namal Nawana as its new chief executive officer, it was reported yesterday.
Nawana has joined the company from medical diagnostics company, Alere, where he was also chief executive officer, and managed its USD5.3bn acquisition by Abbott last year. Prior to Alere, Nawana spent more than 15 years at Johnson & Johnson, primarily in its medical devices and diagnostics segment.
Roberto Quarta, chairman of Smith & Nephew, said, 'Namal has the experience as a CEO of a major listed company in the healthcare sector, and has demonstrated that he can energise businesses to deliver better performance and greater value to shareholders.'
Personalis validates NeXT Personal test for ultra-sensitive MRD detection
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Scancell initiates SCOPE trial's iSCIB1+ cohort
Valneva launches Phase 1 trial for next-generation Zika vaccine
Bio-Thera Solutions' BAT8006 phase II Study receives US FDA IND approval
Lipocine doses first cohort in LPCN 1154 study
Poseida Therapeutics names new chief medical officer
Biocytogen and ABL Bio collaborate on development of new bispecific antibody-drug conjugates